메뉴 건너뛰기




Volumn 27, Issue 3, 2012, Pages 337-345

Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model

Author keywords

Breast cancer; Fibroblast growth factor; Progesterone; Vascular endothelial growth factor

Indexed keywords

FGF4 PROTEIN, HUMAN; FGF8 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 8; MESSENGER RNA; PROGESTERONE;

EID: 84857715740     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (34)
  • 1
    • 0031807196 scopus 로고    scopus 로고
    • The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7)
    • Bagheri-Yarmand R., Kourbali Y., Mabilat C., Morère J.F., Martin A., Lu H., Soria C., Jozefonvicz J. and Crépin M. (1998). The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). Br. J. Cancer 78, 111-118.
    • (1998) Br. J. Cancer , vol.78 , pp. 111-118
    • Bagheri-Yarmand, R.1    Kourbali, Y.2    Mabilat, C.3    Morère, J.F.4    Martin, A.5    Lu, H.6    Soria, C.7    Jozefonvicz, J.8    Crépin, M.9
  • 2
    • 27744587931 scopus 로고    scopus 로고
    • Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene
    • Barclay C., Li A.W., Geldenhuys L., Baguma-Nibasheka M., Porter G.A., Veugelers P.J., Murphy P.R. and Casson A.G. (2005). Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin. Cancer Res. 11, 7683-7691.
    • (2005) Clin. Cancer Res , vol.11 , pp. 7683-7691
    • Barclay, C.1    Li, A.W.2    Geldenhuys, L.3    Baguma-Nibasheka, M.4    Porter, G.A.5    Veugelers, P.J.6    Murphy, P.R.7    Casson, A.G.8
  • 4
  • 5
    • 0030880344 scopus 로고    scopus 로고
    • Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma
    • Colomer R., Aparicio J., Montero S., Guzmán C., Larrodera L. and Cortés-Funes H. (1997). Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. Br. J. Cancer 76, 1215-1220.
    • (1997) Br. J. Cancer , vol.76 , pp. 1215-1220
    • Colomer, R.1    Aparicio, J.2    Montero, S.3    Guzmán, C.4    Larrodera, L.5    Cortés-Funes, H.6
  • 6
    • 0036175799 scopus 로고    scopus 로고
    • Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer
    • Faridi A., Rudlowski C., Biesterfeld S., Schuh S., Rath W. and Schröder W. (2002). Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer. Pathol. Res. Pract. 198, 1-5.
    • (2002) Pathol. Res. Pract , vol.198 , pp. 1-5
    • Faridi, A.1    Rudlowski, C.2    Biesterfeld, S.3    Schuh, S.4    Rath, W.5    Schröder, W.6
  • 7
    • 78751488034 scopus 로고    scopus 로고
    • MCF-7 cell apoptosis and cell cycle arrest: Non-genomic effects of progesterone and mifepristone (RU-486)
    • Fjelldal R., Moe B.T., Ørbo A. and Sager G. (2010). MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486). Anticancer Res. 30, 4835-40.
    • (2010) Anticancer Res , vol.30 , pp. 4835-4840
    • Fjelldal, R.1    Moe, B.T.2    ørbo, A.3    Sager, G.4
  • 9
    • 85010755483 scopus 로고    scopus 로고
    • Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: Useful as diagnostic tools?
    • Granato A.M., Nanni O., Falcini F., Folli S., Mosconi G., De Paola F., Medri L., Amadori D. and Volpi A. (2004). Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? Breast Cancer Res. 6, R38-45.
    • (2004) Breast Cancer Res , vol.6
    • Granato, A.M.1    Nanni, O.2    Falcini, F.3    Folli, S.4    Mosconi, G.5    de Paola, F.6    Medri, L.7    Amadori, D.8    Volpi, A.9
  • 11
    • 0032005986 scopus 로고    scopus 로고
    • Progestin regulation of vascular endothelial growth factor in human breast cancer cells
    • Hyder S.M., Murthy L. and Stancel G.M. (1998). Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res. 58, 392-395.
    • (1998) Cancer Res , vol.58 , pp. 392-395
    • Hyder, S.M.1    Murthy, L.2    Stancel, G.M.3
  • 12
    • 0035874047 scopus 로고    scopus 로고
    • Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells
    • Hyder S.M., Chiappetta C. and Stancel G.M. (2001). Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int. J. Cancer 92, 469-473.
    • (2001) Int. J. Cancer , vol.92 , pp. 469-473
    • Hyder, S.M.1    Chiappetta, C.2    Stancel, G.M.3
  • 13
    • 78349246291 scopus 로고    scopus 로고
    • Mammary gland growth factors: Roles in normal development and in cancer
    • Hynes N.E. and Watson C.J. (2010). Mammary gland growth factors: roles in normal development and in cancer. Cold Spring Harb. Perspect. Biol. 2:a003186.
    • (2010) Cold Spring Harb. Perspect. Biol , vol.2
    • Hynes, N.E.1    Watson, C.J.2
  • 14
    • 33750336566 scopus 로고    scopus 로고
    • The effect of progesterone, Testosterone and synthetic progestogens on growth factor-and estradiol-treated human cancerous and benign breast cells
    • Krämer E.A., Seeger H., Krämer B., Wallwiener D. and Mueck A.O. (2006). The effect of progesterone, Testosterone and synthetic progestogens on growth factor-and estradiol-treated human cancerous and benign breast cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 129, 77-83.
    • (2006) Eur. J. Obstet. Gynecol. Reprod. Biol , vol.129 , pp. 77-83
    • Krämer, E.A.1    Seeger, H.2    Krämer, B.3    Wallwiener, D.4    Mueck, A.O.5
  • 15
    • 1642344519 scopus 로고    scopus 로고
    • Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2
    • Levin E.G., Sikora L., Ding L., Rao S.P. and Sriramarao P. (2004). Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2. Am. J. Pathol. 164,1183-1190.
    • (2004) Am. J. Pathol , vol.164 , pp. 1183-1190
    • Levin, E.G.1    Sikora, L.2    Ding, L.3    Rao, S.P.4    Sriramarao, P.5
  • 16
    • 35448981411 scopus 로고    scopus 로고
    • Progestin-dependent progression of human breast tumor xenografts: A novel model for evaluating antitumor therapeutics
    • Liang Y., Besch-Williford C., Brekken R.A. and Hyder S.M. (2007). Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics. Cancer Res. 67, 9929-9936.
    • (2007) Cancer Res , vol.67 , pp. 9929-9936
    • Liang, Y.1    Besch-Williford, C.2    Brekken, R.A.3    Hyder, S.M.4
  • 17
    • 77957723055 scopus 로고    scopus 로고
    • Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice
    • Liang Y., Benakanakere I., Besch-Williford C., Hyder R.S., Ellersieck M.R. and Hyder S.M. (2010). Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice. Menopause 17, 1040-1047.
    • (2010) Menopause , vol.17 , pp. 1040-1047
    • Liang, Y.1    Benakanakere, I.2    Besch-Williford, C.3    Hyder, R.S.4    Ellersieck, M.R.5    Hyder, S.M.6
  • 18
    • 0026696081 scopus 로고
    • Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues
    • Luqmani Y.A., Graham M. and Coombes R.C. (1992). Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br. J. Cancer 66, 273-280.
    • (1992) Br. J. Cancer , vol.66 , pp. 273-280
    • Luqmani, Y.A.1    Graham, M.2    Coombes, R.C.3
  • 19
    • 0032720654 scopus 로고    scopus 로고
    • Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells
    • Maloof P., Wang Q., Wang H., Stein D., Denny T.N., Yahalom J., Fenig E. and Wieder R. (1999). Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 56, 153-67.
    • (1999) Breast Cancer Res. Treat , vol.56 , pp. 153-167
    • Maloof, P.1    Wang, Q.2    Wang, H.3    Stein, D.4    Denny, T.N.5    Yahalom, J.6    Fenig, E.7    Wieder, R.8
  • 21
    • 0025053671 scopus 로고
    • Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor
    • Meyer M.E., Pornon A., Ji J.W., Bocquel M.T., Chambon P. and Gronemeyer H. (1990). Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J. 9, 3923-3932.
    • (1990) EMBO J , vol.9 , pp. 3923-3932
    • Meyer, M.E.1    Pornon, A.2    Ji, J.W.3    Bocquel, M.T.4    Chambon, P.5    Gronemeyer, H.6
  • 22
    • 0035081241 scopus 로고    scopus 로고
    • Fibroblast growth factors
    • Ornitz D.M. and Itoh N. (2001). Fibroblast growth factors. Genome Biol. 2, 1-12.
    • (2001) Genome Biol , vol.2 , pp. 1-12
    • Ornitz, D.M.1    Itoh, N.2
  • 26
    • 0030011512 scopus 로고    scopus 로고
    • Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours
    • Schmitt J.F., Susil B.J. and Hearn M.T. (1996). Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours. Growth Factors 13, 19-35.
    • (1996) Growth Factors , vol.13 , pp. 19-35
    • Schmitt, J.F.1    Susil, B.J.2    Hearn, M.T.3
  • 27
    • 70249146546 scopus 로고    scopus 로고
    • Fibroblast growth factors in development and cancer: Insights from the mammary and prostate glands
    • Schwertfeger K.L. (2009). Fibroblast growth factors in development and cancer: insights from the mammary and prostate glands. Curr. Drug Targets 10, 632-44.
    • (2009) Curr. Drug Targets , vol.10 , pp. 632-644
    • Schwertfeger, K.L.1
  • 28
    • 34547662090 scopus 로고    scopus 로고
    • Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells
    • Shi Y.H., Bingle L., Gong L.H., Wang Y.X., Corke K.P. and Fang W.G. (2007). Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Pathology 39, 396-400.
    • (2007) Pathology , vol.39 , pp. 396-400
    • Shi, Y.H.1    Bingle, L.2    Gong, L.H.3    Wang, Y.X.4    Corke, K.P.5    Fang, W.G.6
  • 29
    • 15444349656 scopus 로고    scopus 로고
    • High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8
    • Tanaka A., Furuya A., Yamasaki M., Hanai N., Kuriki K., Kamiakito T., Kobayashi Y., Yoshida H., Koike M. and Fukayama M. (1998). High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res. 58, 2053-2056.
    • (1998) Cancer Res , vol.58 , pp. 2053-2056
    • Tanaka, A.1    Furuya, A.2    Yamasaki, M.3    Hanai, N.4    Kuriki, K.5    Kamiakito, T.6    Kobayashi, Y.7    Yoshida, H.8    Koike, M.9    Fukayama, M.10
  • 31
    • 0029757966 scopus 로고    scopus 로고
    • 16·-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity
    • Wagner B.L., Pollio G., Leonhardt S., Lee D.Y.W., Imhof M.O., Edwards D.P., Cook C.E. and McDonnell D.P. (1996). 16·-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Pharmacology 93, 8739-8744
    • (1996) Pharmacology , vol.93 , pp. 8739-8744
    • Wagner, B.L.1    Pollio, G.2    Leonhardt, S.3    Lee, D.Y.W.4    Imhof, M.O.5    Edwards, D.P.6    Cook, C.E.7    McDonnell, D.P.8
  • 33
    • 85047698654 scopus 로고    scopus 로고
    • Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer
    • Zammit C., Coope R., Gomm J.J., Shousha S., Johnston C.L. and Coombes R.C. (2002). Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer. Br. J. Cancer 86, 1097-1103.
    • (2002) Br. J. Cancer , vol.86 , pp. 1097-1103
    • Zammit, C.1    Coope, R.2    Gomm, J.J.3    Shousha, S.4    Johnston, C.L.5    Coombes, R.C.6
  • 34
    • 33744937606 scopus 로고    scopus 로고
    • Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family
    • Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M. and Ornitz D.M. (2006). Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694-15700.
    • (2006) J. Biol. Chem , vol.281 , pp. 15694-15700
    • Zhang, X.1    Ibrahimi, O.A.2    Olsen, S.K.3    Umemori, H.4    Mohammadi, M.5    Ornitz, D.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.